Clinical significance of circulating anti-p53 antibodies in European patients with hepatocellular carcinoma

p53 alterations are considered to be predictive of poor prognosis in hepatocellular carcinoma (HCC) and may induce a humoral response. Anti-p53 serum antibodies were assessed by enzyme-linked immunosorbent assay (ELISA) using purified recombinant human p53 on 130 European HCC patients before treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Saffroy, R, Lelong, J-C, Azoulay, D, Salvucci, M, Reynes, M, Bismuth, H, Debuire, B, Lemoine, A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362420/
https://www.ncbi.nlm.nih.gov/pubmed/10027337
http://dx.doi.org/10.1038/sj.bjc.6690095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362420/
https://www.ncbi.nlm.nih.gov/pubmed/10027337
http://dx.doi.org/10.1038/sj.bjc.6690095

Ejemplares similares